Cite
HARVARD Citation
Rapoport, B. et al. (2016). Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy. European journal of cancer. pp. 23-30. [Online].